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1. A small percentage of women describe a prominent dysphoric disturbance that is present 
during the premenstrual week, remits soon after the onset of menses and produces 
significant impairment in domestic, social or occupational functioning. 
2. Premenstrual dysphoric disorder must be distinguished from minor premenstrual emotional 
changes, from dysmenorrhea and from premenstrual exacerbations of psychiatric illness. 
Diagnostic evaluation should include the prospective assessment of symptoms over at least 
two complete menstrual cycles. 
3. Although the pathophysiology of premenstrual dysphoric disorder is linked to cycling of 
the intact hypothalamo-pituitary-gonadal axis, many studies have contained serious 
methodological weaknesses and no single etiological theory has received widespread support. 
4. No single pharmacological treatment has been shown to be clearly more effective than 
placebo in controlled studies and premenstrual dysphoric disorder appears to respond 
favorably to most interventions in uncontrolled studies. Interruption of pituitary-ovarian 
cycling will alleviate premenstrual symptoms, but treatments of this type cannot be 
recommended for general use until potential hazards are clarified. 
Keywords: diagnosis, menstrual cycle, ovarian hormones, premenstrual dysphoric disorder, 
premenstrual syndrome 
Abbreviations: premenstrual dysphoric disorder (PDD), premenstrual syndrome (PMS), 
hypothalamo-pituitary-gonadal (HPG) axis 
1. Introduction 
Recurrent emotional and behavioral changes have been noted to occur in some women before 
the onset of their menses. Although these phenomena have been described for many years 
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(DeWees 1840), there has been a resurgence of interest in recent years. This paper will 
review the essential descriptive characteristics of premenstrual syndrome (PMS), discuss 
the differential diagnoses that are relevant when evaluating complaints of premenstrual 
distress, summarize our current understanding of the etiology and pathophyslology of PMS 
and critically examine the recommended treatment interventions. 
More than 50 years ago, Frank (1931) graphically described a condition that he named 
premenstrual tension’. He reported on a group of women who “complain of a feeling of 
indescribable tension from ten to seven days preceding menstruation which, in most 
instances, continues until the time that menstrual flow occurs. These patients complain of 
unrest, irritability, ‘like jumping out of their skin’ and a desire to find relief by 
foolish and ill considered actions. Their personal suffering is intense and manifests 
itself in many reckless and sometimes reprehensible actions. Not only do they realize 
their own suffering, but they feel conscience-stricken towards their husbands and families, 
knowing well that they are unbearable in their attitude and reactions. Within an hour or 
two after the onset of the menstrual flow complete relief from both physical and mental 
tension occurs.” 
Today, premenstrual disturbances are receiving attention in a number of different and 
controversial ways. On the one hand, there are clinicians from many different disciplines 
who are stressing that these conditions are ‘real, not imagined’ and are aggressively 
marketing their favored treatment approaches. Conversely, other investigators question the 
existence of a discrete disorder and suggest that flawed research methods and negative 
social attitudes towards women have played a major role in generating findings of 
premenstrual dysfunction. Still others acknowledge that significant problems do occur in 
some women premenstrually but utilize a dichotomous mind-body approach that places greater 
emphasis on an ‘organic’ rather than ‘psychiatric’ etiology. They insist that, although 
emotional and behavioral change are the predominant clinical features, a psychiatric 
diagnosis for premenstrual syndrome will increase discrimination against women. 
Frank’s description highlights some of the issues that are often under-emphasized in 
current discussions. He was referring to women who had identified themselves as patients 
and who had sought his assistance in the hope that he could provide them with some relief 
from their distress. He identified a group of symptoms and signs that recurred regularly 
during a specific phase of the menstrual cycle and, according to standard nosological 
practice, this constituted a clinical syndrome. Since then, the literature has contained 
numerous reports of women presenting with similar emotional and behavioral complaints 
during the premenstruum. Several comprehensive reviews have been published (Steiner and 
Carroll, 1977; Abplanalp et a1.,1980; Dalton, 1982; Clare, 1983; Halbreich and Endicott, 
1985) and these studies will not be considered in detail here. Concurrently however, many 
other reports have appeared that failed to detect significant premenstrual dysfunction in 
large groups of normal volunteers and questioned the existence of a premenstrual disorder. 
These findings have been discussed in reviews by Parlee (1973), Ruble (1977) and Sommer 
(1983). This apparent contradiction can be understood if it is recognized that, while data 
from normal volunteers have clearly refuted the suggestion that premenstrual dysfunction 
occurs in most women, these studies do not address the experiences of the small percentage 
of women who continue to request help for premenstrual symptoms. Recent efforts to improve 
the definition of this clinical disturbance are aimed at facilitating research into the 
epidemiology, cause and effective treatments for this condition. 
2. Diagnosis 
2.1. Defining characteristics of PMS 
Examination of the literature reveals that the term ‘uremenstrual syndrome’ or PMS has 
been used to include disturbances with a wide variation in features and overall severity. 
There are however, two major dimensions to the defining characteristics of this syndrome: 
the timing of the disturbance in relation to the menstrual cycle and the typical clinical 
features. The diagnostic features will be examined in a discussion of the proposed 
criteria for a category called Premenstrual Dysphoric Disorder (PDD) that is being 
considered for inclusion in the revision of the Diagnostic and Statistical Manual of Mental 
Disorders, Third Edition (DSM IIIR). The draft criteria are listed in Table 1. 
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Table I 
Diagnostic Criteria for Premenstrual Dysphoric Disorder 
A. For most menstrual cycles during the past vear, symptoms in B were present during the 
week prior to menses, and disappeared within a few days of the onset of menses. 
B. At least five of the following symptoms were present for most of the time during each 












marked affective labil.ity, e.g. suddenly sad, tearful, irritable, or angry 
persistent and marked anger or irritability 
feeling extremely tense, keyed up, or on edge 
markedly depressed mood, marked pessimism, or self-deprecating thoughts 
loss of interest in usual activities, e.g. work, friends, hobbies 
easily tired or lack of energy 
subjective sense of difficulty concentrating 
marked change in appetite, overeating, or specific food cravings 
insomnia or hypersomnia 
other physical symptoms, such as breast tenderness or swelling, headaches, 
joint or muscle pain, sensation of 'bloating', weight gain 
C. The disturbance seriously interferes with work or with usual social activities or 
relationships with others. 
D. The disturbance is not merely an exacerbation of the symptoms of another disorder, 
such as Major Depression, Panic Disorder, Dysthymtc Disorder, or a Personality Disorder. 
E. Criteria A, B, C, and D are confirmed by prospective daily self-ratings of at least 
two symptomatic cycles. 
2.2. Temporal criterion 
Criterion A emphasises the recurrent and time-limited character of this disorder. It 
must have been present during many menstrual cycles and predominantly affect the 
premenstrual week. This does not exclude those disorders that appear at midcycle, 
coincident with ovulation, and continue through most of the luteal phase, or those that 
gradually remit over the first few days of menses. The essential feature is a complete 
remission of the disturbance for the majority of the follicular phase. This follicular 
remission distinguishes a time-limited disorder like PDD from a premenstrual worsening of a 
chronic condition. 
2.3. Clinical features 
The clinical features of PDD are listed under criterion B. These can be grouped into 
three areas: emotional, behavioral and somatic. Many studies in recent years have added to 
the list of features seen in PMS and included virtually any symptom that has been observed 
during the premenstruum (Dalton 1977). These reports give insufficient attention to the 
distinction between typical changes and incidental findings. One attempt to characterize 
the specific features of a severe premenstrual disturbance utilized a group of women with 
severe PMS and no other evidence of psychopathology or physical illness (Haskett et al 
1980). In these women the MW items 'irritability' and 'mood swings' changed most in 
severlty between the follicular and premenstrual phases in the greatest number of subjects. 
'Restlessness', 'tension', 'depression', and 'anxiety' were the next most highly ranked 
items of emotional change. 'Swelling of abdomen, breasts and ankles' and 'painful or 
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tender breasts' were the two most commonly reported somatic changes and the next five items 
included a perceived difficulty in concentration, forgetfulness, distractibility and 
decreased efficiency. Changes in sleep, appetite and energy were also frequently 
mentioned. The findings of this study were incorporated into an earlier system of 
restrictive and operationally defined diagnostic criteria for a premenstrual tension 
syndrome (Steiner et al 1980). 
2.4. Severity criterion 
It must be stressed that the changes listed above were identified in a group of women who 
were suffering from a much more severe disturbance overall than has been found in studies 
of presumptively normal volunteers. Failure to recognize the importance of the severity 
criterion has contributed much to the controversy around the validity of a PMS diagnostic 
category. Epidemiological studies suggest that, despite a high prevalence of mild 
premenstrual changes, severe premenstrual disturbance is uncommon in the general 
population. For example, almost all women (98%) attending a family practice reported some 
premenstrual change in at least one of 34 self-rated items (Clare 1983), but the 
distribution of total scores was markedly skewed and most women reported minimal 
disturbance. Andersch et al (1980) surveyed an urban population of 1,083 women and found 
that, whereas 92% reported at least one premenstrual change , severe symptoms were similarly 
infrequent. Seventy percent of women described the changes as mild or moderate, only 10% 
would have welcomed treatment and severe distressing symptoms were very uncommon (2-3X). 
Criterion C should restrict the diagnosis of PDD to those few women in whom the 
premenstrual changes are associated with serious impairment of functi0ning.t 
2.5. Differential diagnosis 
Many emotlonal disorders have been noted to exacerbate during the premenstruum and 
criterion D attempts to distinguish this situatlon from a disorder that is limited to the 
premenstruum. Studies in Britain, Denmark and the United States have found that women 
admitted to hospital with a psychiatric diagnosis are more likely to be in the uremenstrual 
or menstrual phases of their cycle than would be expected bv chance (Dalton 1959, Kramp 
1968, Janowsky et al, 1969). A recent report suggests that this interaction between 
menstrual cycle phase and hospitalization is related to the patient's diagnosis (Abramowitz 
et al 1982). Women with a diagnosis of schizophrenia did not appear to be admitted more 
frequently around the time of menses whereas 41% of admissions for depression occurred on 
the last premenstrual day or first day of menstrual flow. Although heuristically 
stimulating, the method of fixing phase of menstrual cycle in these studies can be 
criticized. The rhythm of the menstrual cycle is clearly vulnerable to disruption by 
environmental stress, illness and many psychotropic medications and the reported date of 
last menstrual period or appearance of menses in hospital are likely to be unreliable 
indicators of menstrual cycle phase at the time of admission. One study that utilized 
endometrial histology to fix menstrual cycle phase at the time of death produced some 
intriguing findings (MacKinnon et al 1959). There was not only an apparent increase during 
the luteal phase in the proportion of deaths by suicide, but deaths due to accident and 
disease were also concentrated into this cycle phase. 
2.6. Prospective confirmation 
The final criterion for the diagnosis of PDD (E) deals with the discrepancies that have 
been noted between retrospective accounts of premenstrual complaints and prospective 
concurrent reports. It has been suggested that retrospective accounts may reveal more 
about societal attitudes and myths about the menstrual cycle than subjectively experienced 
changes (Abplanalp et al 1980, Ruble 1977, Ruble and Brooks-Gunn 1979). In one study, a 
group of women with a history of severe premenstrual disturbance were divided according to 
whether their concurrent self-reports in the follicular and premenstrual phases confirmed 
that their disturbance was both severe and time-limited (Haskett and Abplanalp 1983). 
Separate daily ratings revealed that only the subgroup with a confirmed disorder actually 
experienced a significant increase in negative mood scores during the premenstruum compared 
to very low levels of symptomatology during the other phases of the cycle. Concurrent 
daily self-ratings over at least two complete cycles will permit the evaluator to 
distinguish between a diagnosis of PDD and premenstrual exacerbations of other disorders, 
or psychopathology that is unrelated to the premenstruum. 
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3. Etiology and Pathophysiology 
Many hypotheses have been considered in attempts to explain the origins of premenstrual 
disorder. Several excellent summaries of this literature have examined the evidence 
supporting or refuting each theory (Steiner and Carroll 1977, Reid and Yen 1980, Rausch and 
Janowsky 1982) and, since no single explanation has been substantiated, these studies will 
not be reviewed in detail in this paper. 
Despite the lack of an identified mechanism, there is an obvious link between 
premenstrual changes and an intact, cycling hypothalamo-pituitary-gonadal (HPG) axis. The 
onset of the disorder occurs after puberty, the disturbance remits during pregnancy, may 
persist after hysterectomy if functioning ovaries remain, 
or spont&eous menopause. 
but will cease after oophorectomy 
It is not surprising therefore, to find that many hypotheses 
have attempted to link the appearance of premenstrual symptoms to an abnormal absolute 
level or ratio of hormones during the menstrual cycle. These include estrogen excess, 
progesterone deficiency, altered estrogen/progesterone ratio and hyperprolactinemia. 
Unfortunately these hormonal abnormalities have not been consistently demonstrated and many 
findings that appeared to support these etiological relationships were obtained from 
studies with serious methodological weaknesses. For example, subject selection criteria 
were vague or imprecise, appropiate control populations were not included, menstrual cycle 
phase was defined by unreliable markers and endocrine function was inferred from single 
blood samples. In addition, most theories fail to account for the absence of symptoms at 
other times when similar hormonal ‘abnormalities’ are present. 
The regulation of the menstrual cycle involves a complex series of interactions between 
brain neurotransmitter systems , pituitary gonadotropins and ovarian steroids. Instead of 
representing the cause of the observed psychopathology, altered levels of peripheral 
hormones may be markers of changes in the central components of the HPG axis and recently, 
more attention has been directed towards the temporal patterns of circulating peripheral 
hormones rather than the absolute levels. Changes in peripheral hormone levels may be 
closely linked to fluctuations in central neurotransmitter systems that, not only 
participate in the regulatory mechanisms of the menstrual cycle, but are capable of 
altering emotions and behavior (Reid 1983). Further studies, in carefully characterized 
populations of women with PMS, should search for abnormal functioning in the dynamic 
systems that have been shown to be involved in the regulation of the normal menstrual 
cycle. 
4. Management 
The literature on the management of premenstrual disorder contains results that are just 
as contradictory and inconclusive as those from investigations into the cause of this 
disturbance. Many of the same methodological concerns are relevant. Although progesterone 
and pyridoxine have been separately promoted as effective treatments for PMS, appropiately 
designed studies have been unable to show a consistent effect. There is minimal evidence 
to support the use of lithium or other antidepressants unless the woman is also suffering 
from a major affective disorder that requires treatment. Interruption of HPG axis cycling 
with danazol (Day 1979, Dennerstein et al 1983) or a gonadotropin-releasing-hormone agonist 
(Muse et al 1984) will produce a remission in the premenstrual disturbance, but this form 
of intervention cannot be recommended for the general treatment of PMS until its potential 
hazards have been more thoroughly assessed. Trials of treatment with oral contraceptives 
have yielded inconsistent results and some women reported a worsening of their symptoms 
(Cullberg 1972). 
PMS appears to respond favorably to most interventions in uncontrolled studies and there 
is a prominent placebo effect in almost all controlled studies (Smith 1975). There is also 
evidence to suggest that monitoring the clinical features is associated with a decrease in 
the level of the disturbance (Harrison et al 1984). The concurrent ratings, an essential 
part of the diagnostic evaluation, are therefore also the first form of intervention. This 
strategy has the advantage of demonstrated efficacy and minimal risk. In addition, many 
women report that some dietary components, such as caffeine-containing foods and drinks, 
and foods with high salt content, aggravate their premenstrual symptoms. Although the 
scientific support for these influences is lacking, simple changes in diet have a low risk 
and may be of benefit. 
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5. Conclusions 
In summary, the diagnosis of PDD depends upon the identification of a time-limited 
premenstrual syndrome that is comprised of the typical clinical features. The overall 
level of disturbance must meet a severity criterion during the premenstrual phase when the 
disorder is present and must also meet a 'normality' criterion during the follicular phase 
when the disorder has remitted. The principle differential diagnoses are premenstrual 
exacerbations of other psychiatric disorder, dysmenorrhea and mild subjective premenstrual 
changes that are not associated with dysfunction. Although the pathophysiology of this 
disorder remains unclear, future studies will continue to examine the dynamic changes in 
the regulatory systems of the HPG axis instead of simply focussing on a search for abnormal 
levels of peripheral hormones. The management of PMS must acknowledge that there is still 
no specific pharmacological treatment with demonstrated efficacy and the choice of any 
intervention should be strongly influenced by the possibility of serious risks or side- 
effects. 
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